Maternal Characteristics Influencing the Development of Gestational Diabetes in Obese Women Receiving 17-alpha-Hydroxyprogesterone Caproate
Saved in:
Main Authors: | Robert Egerman (Author), Risa Ramsey (Author), Niki Istwan (Author), Debbie Rhea (Author), Gary Stanziano (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro
by: Morrison John J, et al.
Published: (2004) -
Patient and Provider Perspectives on Acceptability, Access, and Adherence to 17-Alpha-Hydroxyprogesterone Caproate for Preterm Birth Prevention
by: Stephanie M. Garcia, et al.
Published: (2021) -
The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
by: Carla E. Ransom, et al.
Published: (2011) -
Pharmacokinetics of Hydroxyprogesterone Caproate and its Primary Metabolites during Pregnancy
by: Kim A. Boggess, et al.
Published: (2018) -
Effect of 17 α-Hydroxyprogesterone Caproate on the Prevention of Preterm Labor: A Randomized Controlled Trial Study
by: Hamed Jafarpour, et al.
Published: (2020)